GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » 1-Year ROIIC %

Dali Pharmaceutical Co (SHSE:603963) 1-Year ROIIC % : -68.07% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Dali Pharmaceutical Co's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was -68.07%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Dali Pharmaceutical Co's 1-Year ROIIC % or its related term are showing as below:

SHSE:603963's 1-Year ROIIC % is ranked worse than
82.08% of 1010 companies
in the Drug Manufacturers industry
Industry Median: 1.6 vs SHSE:603963: -68.07

Dali Pharmaceutical Co 1-Year ROIIC % Historical Data

The historical data trend for Dali Pharmaceutical Co's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dali Pharmaceutical Co 1-Year ROIIC % Chart

Dali Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 201.30 -38.98 -66.87 524.22 57.47

Dali Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,067.51 57.47 135.97 -31.68 -68.07

Competitive Comparison of Dali Pharmaceutical Co's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Dali Pharmaceutical Co's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dali Pharmaceutical Co's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dali Pharmaceutical Co's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Dali Pharmaceutical Co's 1-Year ROIIC % falls into.



Dali Pharmaceutical Co 1-Year ROIIC % Calculation

Dali Pharmaceutical Co's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -30.5115 (Sep. 2024) - -24.9685 (Sep. 2023) )/( 213.64 (Sep. 2024) - 205.497 (Sep. 2023) )
=-5.543/8.1430000000001
=-68.07%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Dali Pharmaceutical Co  (SHSE:603963) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Dali Pharmaceutical Co 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dali Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
Executives
Wu Pei Rong senior management
Yang Jun Xiang Directors, senior managers
Yang Jun Wei Director

Dali Pharmaceutical Co Headlines

No Headlines